Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
University of Hawaii Cancer Center
mi
from
Honolulu, HI
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
University of Hawaii Cancer Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Saint Vincent Hospital and Health Care Center
mi
from
Indianapolis, IN
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Saint Vincent Hospital and Health Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
University of Kansas Cancer Center
mi
from
Kansas City, KA
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
University of Kansas Cancer Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Michigan State University Clinical Center
mi
from
East Lansing, MI
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Michigan State University Clinical Center
mi
from
East Lansing, MI
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
The Mayo Clinic
mi
from
Rochester, MN
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Ellis Fischel Cancer Center
mi
from
Columbia, MO
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Ellis Fischel Cancer Center
mi
from
Columbia, MO
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Morristown Medical Center
mi
from
Morristown, NJ
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
New York Medical College
mi
from
Valhalla, NY
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Dayton Children's Hospital
mi
from
Dayton, OH
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Dayton Children's Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Greenville Cancer Treatment Center
mi
from
Greenville, SC
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Greenville Cancer Treatment Center
mi
from
Greenville, SC
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Marshfield Clinic
mi
from
Marshfield, WI
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated:  4/8/2016
Royal Brisbane and Women's Hospital
mi
from
Herston,
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A Study of Neurocognitive Function in Children Treated for ALL
Status: Enrolling
Updated: 4/8/2016
Royal Brisbane and Women's Hospital
mi
from
Herston,
Click here to add this to my saved trials
Treating Oxidative Stress and the Metabolic Pathology of Autism
Treating Oxidative Stress and the Metabolic Pathology of Autism
Status: Enrolling
Updated:  4/8/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Treating Oxidative Stress and the Metabolic Pathology of Autism
Treating Oxidative Stress and the Metabolic Pathology of Autism
Status: Enrolling
Updated: 4/8/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Rapamycin vs Methotrexate in Diffuse SSc
A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral Rapamycin Versus Methotrexate in Systemic Sclerosis (Scleroderma)
Status: Enrolling
Updated:  4/8/2016
Philip Clements, MD
mi
from
Los Angeles, CA
Rapamycin vs Methotrexate in Diffuse SSc
A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral Rapamycin Versus Methotrexate in Systemic Sclerosis (Scleroderma)
Status: Enrolling
Updated: 4/8/2016
Philip Clements, MD
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of D-Cycloserine in Children With Autism
A Randomized Controlled Trial of D-Cycloserine in Autism
Status: Enrolling
Updated:  4/8/2016
Riley Hospital for Children, Christian Sarkine Autism Treatment Center
mi
from
Indianapolis, IN
Safety and Effectiveness of D-Cycloserine in Children With Autism
A Randomized Controlled Trial of D-Cycloserine in Autism
Status: Enrolling
Updated: 4/8/2016
Riley Hospital for Children, Christian Sarkine Autism Treatment Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
Long Beach, CA
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
San Francisco, CA
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
Tampa, FL
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
Vero Beach, FL
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
Vero Beach, FL
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
Abington, PA
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
Abington, PA
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
Round Rock, TX
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
Clinical Research Facility
mi
from
Charlotte, NC
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  4/9/2016
mi
from
Bruxelles,
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 4/9/2016
mi
from
Bruxelles,
Click here to add this to my saved trials
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated:  4/11/2016
Methodist Center for Geriatric Medicine
mi
from
Indianapolis, IN
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated: 4/11/2016
Methodist Center for Geriatric Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated:  4/11/2016
St. Vincent Center for Healthy Aging
mi
from
Indianapolis, IN
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated: 4/11/2016
St. Vincent Center for Healthy Aging
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated:  4/11/2016
Touchpoint
mi
from
Fishers, IN
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated: 4/11/2016
Touchpoint
mi
from
Fishers, IN
Click here to add this to my saved trials
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated:  4/11/2016
University Clinical Neurology
mi
from
Indianapolis, IN
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated: 4/11/2016
University Clinical Neurology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated:  4/11/2016
Wishard Health Services
mi
from
Indianapolis, IN
Comparative Research of Alzheimer's Disease Drugs
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
Status: Enrolling
Updated: 4/11/2016
Wishard Health Services
mi
from
Indianapolis, IN
Click here to add this to my saved trials
External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy
External Trigeminal Nerve Stimulation for Epilepsy
Status: Enrolling
Updated:  4/11/2016
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy
External Trigeminal Nerve Stimulation for Epilepsy
Status: Enrolling
Updated: 4/11/2016
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Pharmacology Research Institute
mi
from
Encino, CA
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Pharmacology Research Institute (PRI)
mi
from
Los Alamitos, CA
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Pharmacology Research Institute (PRI)
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Pharmacology Research Institute (PRI)
mi
from
Newport Beach, CA
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Pharmacology Research Institute (PRI)
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
NRC Research Institute
mi
from
Orange, CA
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Elite Clinical Trials
mi
from
Wildomar, CA
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Elite Clinical Trials
mi
from
Wildomar, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
MCB Clinical Research
mi
from
Colorado Springs, CO
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
MCB Clinical Research
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Gulfcoast Clinical Research Center
mi
from
Fort Myers, FL
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Gulfcoast Clinical Research Center
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Sarkis Clinical Trials
mi
from
Gainesville, FL
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/11/2016
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/11/2016
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials